User profiles for Fernando Palluzzi

Fernando Palluzzi

Università degli Studi di Pavia
Verified email at ieo.it
Cited by 572

GenoMetric Query Language: a novel approach to large-scale genomic data management

…, P Pinoli, F Venco, A Kaitoua, V Jalili, F Palluzzi… - …, 2015 - academic.oup.com
Motivation: Improvement of sequencing technologies and data processing pipelines is
rapidly providing sequencing data, with associated high-level features, of many individual …

Release of paused RNA polymerase II at specific loci favors DNA double-strand-break formation and promotes cancer translocations

GI Dellino, F Palluzzi, AM Chiariello, R Piccioni… - Nature …, 2019 - nature.com
It is not clear how spontaneous DNA double-strand breaks (DSBs) form and are processed
in normal cells, and whether they predispose to cancer-associated translocations. We show …

Classification accuracy of transcranial magnetic stimulation for the diagnosis of neurodegenerative dementias

A Benussi, M Grassi, F Palluzzi, G Koch… - Annals of …, 2020 - Wiley Online Library
Objective Transcranial magnetic stimulation (TMS) has been suggested as a reliable,
noninvasive, and inexpensive tool for the diagnosis of neurodegenerative dementias. In this study, …

[HTML][HTML] Classification accuracy of TMS for the diagnosis of mild cognitive impairment

A Benussi, M Grassi, F Palluzzi, V Cantoni, MS Cotelli… - Brain Stimulation, 2021 - Elsevier
Objective To evaluate the performance of a Random Forest (RF) classifier on Transcranial
Magnetic Stimulation (TMS) measures in patients with Mild Cognitive Impairment (MCI). …

[HTML][HTML] A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia

R Ferrari, M Grassi, E Salvi, B Borroni, F Palluzzi… - Neurobiology of …, 2015 - Elsevier
Frontotemporal dementia (FTD) is the second most prevalent form of early onset dementia
after Alzheimer's disease (AD). We performed a case-control association study in an Italian …

[HTML][HTML] Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients

M Buttarelli, A Ciucci, F Palluzzi, G Raspaglio… - Journal of Experimental …, 2022 - Springer
Background High-grade serous ovarian cancer (HGSOC) has poor survival rates due to a
combination of diagnosis at advanced stage and disease recurrence as a result of …

[HTML][HTML] Bioinformatics: from NGS data to biological complexity in variant detection and oncological clinical practice

…, C Roma, D Guido, A Preziosi, B Tropea, F Palluzzi… - Biomedicines, 2022 - mdpi.com
The use of next-generation sequencing (NGS) techniques for variant detection has become
increasingly important in clinical research and in clinical practice in oncology. Many cancer …

[HTML][HTML] BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely …

…, M Bianchi, T Pasciuto, I Mozzetta, F Palluzzi… - Trials, 2022 - Springer
Background Extremely low gestational age neonates (ELGANs, ie, neonates born before 28
weeks of gestation) are at high risk of developing retinopathy of prematurity (ROP), with …

[HTML][HTML] Brain connectivity and information-flow breakdown revealed by a minimum spanning tree-based analysis of MRI data in behavioral variant frontotemporal …

…, E Premi, V Cristillo, S Gazzina, F Palluzzi… - Frontiers in …, 2019 - frontiersin.org
Brain functional disruption and cognitive shortfalls as consequences of neurodegeneration
are among the most investigated aspects in current clinical research. Traditionally, specific …

[HTML][HTML] The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study

…, ML Calcagni, V Rufini, D Guido, F Palluzzi… - European Journal of …, 2022 - Springer
Purpose To investigate whether the COVID-19 pandemic and national lockdown had an
impact on the extent of cancer disease at FDG PET/CT staging as surrogate marker. Methods …